Latest Regulatory Approval News

Page 233 of 236
Imricor Medical Systems reports strong Q4 CY24 progress with successful FDA review, CE Mark submissions, and an 840% jump in consumables revenue, positioning the company for expanded global market penetration.
Ada Torres
Ada Torres
23 Jan 2025
Orpheus Uranium Limited reports a productive December quarter marked by a successful $1.66 million capital raise, completion of a major gravity survey at Mount Douglas, and ongoing progress toward regulatory approvals for advanced uranium exploration.
Maxwell Dee
Maxwell Dee
23 Jan 2025
Chalice Mining reports a robust cash position of approximately $90 million and no debt as it progresses the Gonneville Project towards a targeted Final Investment Decision in 2027. The appointment of Dan Brearley as COO signals strengthened operational leadership amid ongoing metallurgical testwork and exploration activities.
Maxwell Dee
Maxwell Dee
23 Jan 2025
Titanium Sands Limited confirms that retention applications for its lapsed Orion Exploration Licences are approved in principle, with formal renewals pending amid Sri Lankan regulatory delays. The company remains confident in progressing its Mannar Island Project and securing necessary environmental and mining approvals.
Maxwell Dee
Maxwell Dee
22 Jan 2025
NuEnergy has finalized the Gas Sales and Purchase Agreement for its Tanjung Enim project and is advancing drilling preparations, marking a key step toward production and revenue generation.
Maxwell Dee
Maxwell Dee
22 Jan 2025
Patagonia Lithium Ltd has announced a maiden JORC Inferred Mineral Resource Estimate of 3.8 million tonnes of Lithium Carbonate Equivalent at its Formentera Lithium Brine Project in Argentina, highlighting significant potential for resource upgrades through ongoing drilling and advanced extraction technology.
Maxwell Dee
Maxwell Dee
22 Jan 2025
Star Minerals secures shareholder approval for its Cobra Uranium Project in Namibia and prepares for maiden drilling, while progressing gold exploration in Western Australia amid a modest capital raise.
Maxwell Dee
Maxwell Dee
22 Jan 2025
Island Pharmaceuticals has enrolled all subjects in the Phase 2b arm of its ISLA-101 dengue fever clinical trial, advancing its antiviral drug development with key results expected in 2025.
Victor Sage
Victor Sage
22 Jan 2025
Element 25 Limited has announced a 107% increase in Ore Reserves at its Butcherbird Manganese Project in Western Australia, now supporting an 18.3-year mine life at 1.1Mtpa production. This milestone underpins the company’s strategic expansion into battery-grade manganese supply for the EV market.
Maxwell Dee
Maxwell Dee
22 Jan 2025
Amcor plc has entered a definitive agreement to acquire Berry Global Group in a $9.9 billion all-stock transaction, aiming to create a global packaging leader. The merger, pending shareholder and regulatory approvals, is expected to close mid-2025.
Maxwell Dee
Maxwell Dee
22 Jan 2025
Bubs Australia has reported a strong Q2 FY25 performance with a positive EBITDA turnaround and robust revenue growth, while advancing its critical FDA clinical trial in the US.
Eva Park
Eva Park
22 Jan 2025
Evolution Mining delivered a standout December quarter with record cash flows, improved safety, and regulatory approval extending Cowal’s mine life to 2042. The company’s growth projects, including the Mungari mill expansion, are progressing ahead of schedule and under budget, positioning Evolution strongly for FY25.
Maxwell Dee
Maxwell Dee
22 Jan 2025